Using a computer-generated randomisation sequence , we assigned patients ( @:@ ; stratified by geographical region and ECOG performance status , with a permuted block method ) to receive panitumumab ( @ mg/kg once every @ weeks ) or cetuximab ( initial dose @ mg/m ( @ ) ; @ mg/m ( @ ) once a week thereafter ) .